Ridgecrest Wealth Partners, LLC Amgen Inc Transaction History

Ridgecrest Wealth Partners, LLC

$190 Million
Q3 2024

A detailed history of Ridgecrest Wealth Partners, LLC transactions in Amgen Inc stock. As of the latest transaction made, Ridgecrest Wealth Partners, LLC holds 4,188 shares of AMGN stock, worth $1.23 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares

4,188

Previous 4,143 1.09%

Holding current value

$1.23 Million

Previous $1.29 Million 4.25%

% of portfolio

0.71%

Previous 0.78%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$309.38 - $337.38 $13,922 - $15,182	45 Added 1.09%	4,188 $1.35 Million
Q2 2024 Aug 05, 2024	SELL	$262.75 - $319.31 $10,510 - $12,772	-40 Reduced 0.96%	4,143 $1.29 Million
Q1 2024 Apr 17, 2024	SELL	$268.87 - $324.56 $9,410 - $11,359	-35 Reduced 0.83%	4,183 $1.19 Million
Q4 2023 Jan 09, 2024	SELL	$255.7 - $288.46 $112,508 - $126,922	-440 Reduced 9.45%	4,218 $1.21 Million
Q2 2023 Jul 31, 2023	BUY	$214.27 - $253.37 $19,284 - $22,803	90 Added 1.97%	4,658 $1.03 Million
Q4 2022 Jan 26, 2023	SELL	$229.03 - $291.01 $5,725 - $7,275	-25 Reduced 0.54%	4,568 $0
Q1 2022 Apr 26, 2022	BUY	$219.27 - $242.57 $32,890 - $36,385	150 Added 3.38%	4,593 $1.11 Million
Q4 2021 Jan 19, 2022	BUY	$198.88 - $227.6 $367,928 - $421,060	1,850 Added 71.35%	4,443 $1 Million
Q3 2021 Nov 03, 2021	BUY	$212.27 - $248.7 $98,493 - $115,396	464 Added 21.79%	2,593 $551,000
Q2 2021 Jul 21, 2021	BUY	$233.58 - $259.14 $107,680 - $119,463	461 Added 27.64%	2,129 $519,000
Q1 2021 May 19, 2021	BUY	$221.91 - $258.6 $370,145 - $431,344	1,668 New	1,668 $415,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $157B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ridgecrest Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ridgecrest Wealth Partners, LLC with notifications on news.

Account

Ridgecrest Wealth Partners, LLC Amgen Inc Transaction History